Analyst Corner: Apollo Hospitals rating ‘buy’; performance to be hit in the near term

By: |
Published: April 6, 2020 1:15:36 AM

FY20/21/22e Ebitda down 4.1/15.1/4.5%; TP cut to Rs 1,550; ‘Buy’ maintained.

APHS does not expect a significant impact on Q4FY20 financials.

APHS has seen a significant decline in patient footfalls on the back of the 21-day nationwide lockdown. Except for emergency cases, both in-patients (IP) and out-patients (OP) volumes have dried up. Due to the postponement of elective surgeries, IP volumes declined by 35-40% to 700-800 admissions per day (vs normal run rate of ~1,200). OP volumes declined by ~90% to 600 registrations per day (vs normal run rate of 6,000 day). Overall bed occupancy has fallen to 40% compared to 69% occupancy at the end of Q3FY20 (APHS cannot cover its operating costs at occupancy below 50% and faces cash burn).

APHS does not expect a significant impact on Q4FY20 financials; however, it sees a larger hit in Q1FY21 due to the lockdown. Along with a decline in domestic OP volume (which acts as main feed for its IP admissions), high-yielding international patients volume (~10% of its IP revenues in FY19) has also dried up.

Q4FY20 preview: We expect IP volume to remain muted for key Chennai and Hyderabad cluster hospitals at 1-1.6% y-o-y range in Q4. Due to lower occupancy and case mix change (lower elective surgeries), we expect overall revenues and Ebitda to decline by 6.3% and 16.9% q-o-q (y-o-y not comparable) on standalone basis.

Maintain Buy: To reflect near-term disruption in the hospitals business, we cut our Ebitda estimates by 4.1/15.1/4.5% for FY20/21/22 respectively. We expect APHS to see normalising operations towards the end of Q1FY21. Despite volatility near term, we believe the long-term outlook for its core hospital business is intact. APHS has no major capex need in the next two to three years. Our DCF driven TP falls to Rs 1,550 (from Rs 1,875) on lower estimates and changes in other DCF inputs.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Liquidity continues to drive up markets, benchmarks gain 6% in a week
2Shrimp exports to US in April higher by 25%
3MSP hike augurs well for cotton sowing but poses a threat to spinners: Icra